Remedium Bio
PrivateLast Round
Series A
Aug 10, 2026
Total Funding Raised
$20.72M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Remedium Bio is a biotechnology company that develops gene therapies for large unmet clinical needs using its proprietary Prometheus™ adjustable gene therapy platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedium Bio Comparables
Compare Remedium Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Addition Therapeutics | 84% | |
| Canary Cure Therapeutics | 79% | |
| Genprex, Inc. | 77% | |
Remedium Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 10, 2026 | ||||
| Seed Round | May 18, 2026 | ||||
| Series A | Sep 8, 2025 | ||||
| Grant | Sep 30, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
Grant | Nov 24, 2023 |
Remedium Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apis Health Angels | Seed |
| Wharton Alumni Angels | Grant |
| Longevitytech.fund | Seed |
| VitaDAO | Grant |
| HKX Capital | Series A |
| Bill & Melinda Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
$10M round led by LifeSpan Vision Ventures.
- Jul 24, 2026
Grew 19% QoQ, from 16 to 19 employees.
Remedium Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remedium Bio's valuation, stock price, and market status.